№ files_lp_3_process_7_101102
File format: docx
Character count: 5199
File size: 74 KB
Year:
2021
Region / City:
San Francisco
Theme:
Bioengineering, Education, University Courses
Document Type:
Course Schedule
Organization / Institution:
UCSF (University of California, San Francisco)
Author:
UCSF Bioengineering Department
Target Audience:
UCSF students, prospective students, faculty, and staff
Period of Validity:
Winter Quarter 2021
Approval Date:
N/A
Date of Changes:
N/A
Course Start Date:
January 4, 2021
Course End Date:
March 28, 2021
Deadline:
January 22, 2021
Fine for Missed Deadline:
$50
Contact Information:
Provided for individual courses
Description:
The document lists the UCSF Bioengineering courses offered during the Winter 2021 quarter, including class times, instructors, and contact information.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2017
Region / City:
New Jersey
Topic:
Postdoctoral Fellowship
Document Type:
Announcement
Organization:
New Jersey Institute of Technology
Author:
Not specified
Target Audience:
Young scientists with a PhD
Effective Period:
N/A
Approval Date:
N/A
Amendment Date:
N/A
Year:
2019
Region / City:
San Francisco, CA
Subject:
PET/MR scanner use for research
Document Type:
Contract Notice
Agency:
Department of Veterans Affairs, VA Sierra Pacific Network (VISN 21), VA Pacific Islands Health Care System
Contract Number:
36C261-19-AP-239696819-1522
Award Date:
04-01-2019
Awardee:
University of California, San Francisco
Awardee Address:
533 Parnassus Ave, Ste U426, San Francisco, CA 94143
Point of Contact:
Daniel Szambelan, [email protected]
Scope of Work:
Use of PET/MR scanner and associated radiology services for research on pain mechanisms using C-11 Carfentanil
NAICS Code:
622110
Funding Source:
Federal
Solicitation Type:
Sole source, firm fixed price
Performance Location:
UCSF Radiology, China Basin, San Francisco, CA
Security Requirements:
Background investigation, fingerprints, OPM e-QIP completion
Data Handling:
Compliance with VA data protection, media sanitization, and NARA records requirements
Year:
2023
Organization:
UCSF Osher Center for Integrative Health
Position Type:
Associate Director of Education
Location:
San Francisco, California, USA
Program Focus:
Integrative health education
Responsibilities:
Leadership in curriculum development, faculty coordination, program evaluation, interprofessional and continuing education
Required Qualifications:
Faculty appointment at UCSF, experience teaching integrative health at UME and GME levels, knowledge of medical education principles, leadership experience
Preferred Qualifications:
Fellowship-trained in integrative medicine, board certification/eligibility, formal medical education training, membership in Haile T. Debas Academy of Medical Educators
Application Deadline:
November 1, 2023
Application Materials:
CV with Educators Portfolio, Letter of Interest, Diversity Statement, References, Letter of support from department chair
Contact:
Angela Sutkaitis, MBA, Chief Administrative Officer, [email protected]
Job Type:
Part-time (10–20% FTE) with annual review
Source Type:
Job description / organizational posting
Agency:
United States Securities and Exchange Commission
Form number:
Form 25
Document type:
Regulatory filing form
Jurisdiction:
United States
Legal basis:
Securities Exchange Act of 1934
Applicable rules:
Rule 12d2-2 (17 CFR 240.12d2-2); Rule 19d-1 (17 CFR 240.19d-1)
OMB control number:
3235-0080
OMB expiration date:
March 31, 2021
Filing system:
EDGAR
Effective delisting period:
10 days after filing
Effective withdrawal of registration period:
90 days after filing
Revision identifier:
SEC 1654 (03-06)
Year:
2025
Region / city:
Australia
Subject:
Oncology, Pharmaceutical Submission
Document Type:
Pharmaceutical Benefits Scheme (PBS) Submission
Organ / Institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
JANSSEN-CILAG PTY LTD
Target Audience:
Medical practitioners, healthcare professionals
Period of validity:
Ongoing
Approval Date:
Pending
Date of modifications:
N/A
Year:
2025
Region / City:
Uganda
Theme:
Procurement, Health Services, Public Contracts
Document Type:
Pre-Qualification Notice
Authority:
Mulago Specialised Women and Neonatal Hospital
Author:
Not specified
Target Audience:
Providers, Contractors, Suppliers
Period of Validity:
2025-2028
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2024
Region / Country:
Australia
Therapeutic Area:
Gastroenterology
Type of Document:
Regulatory submission / PBAC evaluation
Product:
Budesonide 4 mg suppository (Budenofalk®)
Comparator:
Budesonide 2 mg foam (Budenofalk®), prednisolone suppositories and enemas, hydrocortisone acetate enemas
Regulatory Authority:
TGA (Therapeutic Goods Administration)
Intended Use:
Short-term treatment of mild to moderate ulcerative colitis limited to the rectum
Prescriber Type:
Medical practitioners, Nurse practitioners
PBS Benefit Type:
Unrestricted
Maximum Quantity:
1 pack, 30 units
Treatment Duration:
up to 8 weeks per script
Clinical Evidence:
Phase 3, randomized, double-blind, double-dummy, non-inferiority trial (BUS-4/UCA)
Year:
2025
Region / City:
Windhoek
Subject:
Public Administration, Consultancy, Research
Document Type:
Official Announcement
Institution:
Namibia Institute of Public Administration and Management (NIPAM)
Author:
NIPAM
Target Audience:
Facilitators, Researchers, Consultants, Public Sector Experts
Period of Validity:
Until 10 February 2025
Approval Date:
Not specified
Date of Last Modification:
Not specified
Year:
2011
Regulation:
The Companies Regulations 2011, as amended
Region / Market:
Johannesburg Stock Exchange (JSE)
Document Type:
Regulatory guidance / compliance document
Scope:
Pre-Listing Statements (PLS), Revised Listing Particulars (RLP), Circulars
Language:
English
Applicable Parties:
Issuers and applicants seeking listing on JSE
Requirements:
Disclosure obligations, material contracts, corporate actions
Website Obligation:
Operational website for disclosure compliance
Audience:
Investors, shareholders
Year:
[Year]
Region / City:
Wellington
Topic:
Securities listing and quotation
Document Type:
Application
Organization:
NZ RegCo
Author:
[Issuer Name]
Target Audience:
NZX, securities issuers
Effective Period:
[Date]
Approval Date:
[Date]
Amendment Date:
[Date]
Year:
2023
Region / city:
Australia
Topic:
Oncology, Pharmaceuticals
Document Type:
Resubmission
Institution:
Australian Government, Pharmaceutical Benefits Advisory Committee
Author:
AstraZeneca Pty Ltd.
Target Audience:
Healthcare professionals, regulatory bodies
Effective Period:
Ongoing
Approval Date:
November 2021
Date of Changes:
November 2021
Note:
Year
Note:
Year
Year:
2021
Region / city:
United States
Subject:
COVID-19, Federal Audit Clearinghouse
Document Type:
Memo
Institution:
Department of Education
Author:
Phillip Juengst, Deputy Assistant Secretary
Target Audience:
Grant recipients of the Department of Education
Effective Date:
August 9, 2021
Date of Approval:
August 4, 2021
Questions:
[email protected]
Period of Applicability:
For single audit submissions on or after August 9, 2021
Document Description:
Guidance on how to report subprogram Assistance Listing Numbers (ALNs) with their alphas in the Federal Audit Clearinghouse single audit submission form for Department of Education programs.
Year:
2021
Region / city:
South Africa
Topic:
Financial Instruments, Exchange-Traded Notes
Document Type:
Listing Announcement
Organ / Institution:
FirstRand Bank Limited
Author:
FirstRand Bank Limited
Target Audience:
Investors, Financial Institutions
Period of Validity:
17 August 2021 – 17 August 2026
Approval Date:
17 August 2021
Amendment Date:
None
Year:
2018
Region / city:
Australia
Topic:
Immunisation, Hepatitis B
Document type:
Report
Agency / institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
Chief Medical Officer
Target audience:
Healthcare professionals, policymakers
Period of validity:
Until 31 December 2019
Date of approval:
June 2018
Date of amendments:
None
Year:
2021
Event:
Expert meeting
Location:
Online
Organization:
UNESCO
Topic:
Intangible cultural heritage, listing mechanisms
Type of document:
Report / Meeting overview
Author:
Rieks Smeets
Target audience:
UNESCO member states, cultural heritage experts
Dates of event:
26–27 May 2021
Time:
13:00–16:00 (Paris time / UTC+2)
Historical period covered:
1960s–2008
Year:
2021
Region / city:
Online
Subject:
Intangible Cultural Heritage
Document type:
Background Paper
Organization:
UNESCO
Author:
UNESCO Secretariat
Target audience:
Experts, States Parties, practitioners in the field of intangible cultural heritage
Duration:
May 2021 – ongoing
Approval date:
Not provided
Amendment date:
Not provided